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Abstract
Background: The German clinical guideline on tobacco addiction recommends that general practitioners (GPs)
provide brief stop-smoking advice to their patients according to the “5A” or the much briefer “ABC” method, but its
implementation is insufficient. A lack of training is one barrier for GPs to provide such advice. Moreover, the respective
effectiveness of a 5A or ABC training regarding subsequent delivery of stop-smoking advice has not been investigated.
We developed a training for GPs according to both methods, and conducted a pilot study with process evaluation to
optimize the trainings according to the needs of GPs. This study aims at evaluating the effectiveness of both trainings.
Methods: A pragmatic 2-arm cluster randomised controlled trial with a pre-post data collection will be conducted in
48 GP practices in North Rhine-Westphalia (Germany). GPs will be randomised to receive a 3.5-h-training in delivering
either 5A or ABC, including peer coaching and intensive role plays with professional actors. The patient-reported
primary outcome (receipt of GP advice to quit: yes/no) and secondary outcomes (recommendation rates of smoking
cessation treatments, group comparison (5A versus ABC): receipt of GP advice to quit) will be collected in smoking
patients routinely consulting their GP within 4 weeks prior, and 4 weeks following the training. Additional secondary
outcomes will be collected at 4, 12 and 26 weeks following the consultation: use of cessation treatments during the
last quit attempt (if so) since the GP consultation, and point-prevalence abstinence rates. The primary data analysis will
be conducted using a mixed-effects logistic regression model with random effects for the cluster variable.
Discussion: If the training increases the rates of delivery of stop-smoking advice, it would offer a low-threshold
strategy for the guideline implementation in German primary care. Should one method prove superior, a more specific
guideline recommendation can be proposed.
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Background
In Germany, over 120,000 people die from smoking each
year [1]. About 14% of the country’s mortality is attribut-
able to smoking [1], with approximately one third of to-
bacco-related deaths occurring during working age,
resulting in a huge individual and societal burden [2].
Compared with other European high income countries
such as the Netherlands (19%), England (17%), or
Sweden (7%) [3], the smoking prevalence in the adult
population in Germany remains high (28%) [4]. More-
over, there is a strong link between lower socioeconomic
status (SES) and higher prevalence of smoking [4],
further increasing health-related inequalities between
people of higher and lower socioeconomic groups [5].
Article 14 of the World Health Organization (WHO)
Framework Convention on Tobacco Control (FCTC) [6],
ratified by Germany in 2004, directs ratifying countries
to promote and assist with tobacco cessation. Guidelines
for the implementation of Article 14 recommend the in-
tegration of brief stop-smoking advice into all health-
care systems using existing health infrastructures that
are easily accessible to smokers (including primary
health care), and ensuring that all health-care workers
are trained to provide such advice to their smoking
patients [6].
Compared to unassisted attempts to quit tobacco use,
brief advice to quit smoking has been found to increase
rates and success of attempts to quit smoking [7], and to
be effective and affordable [8]. Higher long-term abstin-
ence rates are achieved when using a combination of
brief medical advice and evidence-based pharmaco-
logical treatment (e.g., nicotine replacement therapy
(NRT), varenicline or buproprion) [9, 10]. Hence,
national and international clinical smoking cessation
guidelines [10–12] recommend that general practitioners
(GPs) should routinely give brief quit-smoking advice to
every smoking patient and make an offer of help to quit.
Approximately two third of all smokers in Germany
report at least one GP visit per year [13]. Hence, appro-
priate interventions to reduce tobacco consumption in
Germany, if implemented in the context of primary care,
could reach the majority of the smoking population
within a relatively short amount of time.
However, implementation of these guidelines into
primary routine care appears to be insufficient. Recent
data from a representative household survey on tobacco
and e-cigarette use in the German population (DEBRA
study, German: “DEutsche Befragung zum RAuchverhal-
ten”, www.debra-study.info) showed that about 80% of
smokers who had reported a GP visit during the previ-
ous year, had not received advice to quit smoking during
this consultation, and barely 4% had been offered an evi-
dence-based cessation method [13]. Comparable data
from England showed that about 60% of smokers re-
ported the receipt of such advice [14]. The combination
of brief advice to quit smoking with or without a recom-
mendation of pharmacotherapy is offered about seven
times more frequently in England [14] than in Germany
(25% vs. 4%) [13]. Thus, GPs in Germany are missing a
prime opportunity to improve the health of their smok-
ing patients. As a consequence, most smokers (> 60%) in
Germany still try to quit smoking unaided or with the
use of non-evidence-based treatments [4, 15] and there-
fore only have a low chance to succeed [16].
Important factors that have been reported as major
barriers for GPs in Germany to routinely provide brief
smoking cessation advice to their patients include the
lack of adequate reimbursement of costs that comes
along with the provision of smoking cessation counsel-
ling for physicians, reimbursement of patients’ costs for
the use of evidence-based smoking cessation treatments,
as well as the lack of time during routine consultations
[17, 18]. As training in smoking cessation promotion is
not a standard part of medical education in Germany,
the lack of training or competence in delivering effective
advice to quit smoking is another frequently reported
major barrier [17–20].
A Cochrane systematic review showed that providing
smoking cessation training to health professionals
significantly increased their performance in delivering
brief behavioural support compared to untrained health
professionals, and had a measurable effect on the point
prevalence of smoking and on continuous abstinence in
patients [21]. However, only few of the included studies
were conducted in the context of primary care. In one
study conducted in London [22], GPs were offered a 40-
min training session addressing the rationale and skills for
referral of smokers for cessation treatment. This interven-
tion significantly increased GP referrals to smoking cessa-
tion services. A more recent study conducted in primary
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care in Greece found that a training of 8 hours together
with two 3-h refresher trainings significantly increased the
rates at which GPs delivered brief stop-smoking advice,
evidence-based smoking cessation treatment, as well as
self-reported knowledge and self-efficacy in providing
such brief counselling at a four-months follow-up [23]. To
date only one cluster randomised trial on providing smok-
ing cessation training has been conducted in GP practices
in Germany, comparing the effect of a training session
together with either physician payment for providing
stop-smoking advice or with patient payment for using
pharmacological therapy [24]. Hence, no conclusions can
be drawn regarding the unique effect of such training in
German primary care.
Whereas the majority of studies offered a treatment
intensity of at least several hours up to days [21, 23],
two recent studies suggest that even short training
sessions of one and respectively 3.5-h can significantly
increase the GP- and patient-reported performance of
delivering brief behavioural support at least in the short-
to mid-term [25, 26]. Moreover, the study of Bobak et al.
[26] shows that such brief training also leads to substan-
tial and sustained changes in GP trainees’ perceived
“Capability” (e.g., knowledge/skills) and “Opportunity” to
provide evidence-based smoking cessation advice [26],
reflecting two of the three determinants of actual Behav-
iour according to the COM-B theory of behaviour [27].
The third determinant “Motivation” was high through-
out the study [26].
The current national guideline [10] for treating tobacco
addiction recommends the delivery of stop-smoking advice
according to the so-called “5A” or “ABC” method. Both
methods differ regarding content and duration. By trad-
ition, the 5A method is used in Germany consisting of the
steps: ask (record and document smoking status of
patients), advise (strongly urge all smokers to quit), assess
(determine willingness to make a quit attempt), assist
(provide evidence-based smoking cessation treatment), and
arrange (follow-up contacts) [11]. According to the 5A
method, assistance would only be offered to smokers stat-
ing their willingness to quit at the time of the consultation
(“opt-in” approach). Smokers unwilling to quit, which is
true for the majority of smokers [28, 29], should be pro-
vided the so-called “5R” approach to enhance motivation to
quit (5R includes a discussion with the smoker about the
risks of continued smoking, the relevance for and rewards
of quitting, potential roadblocks, and the repetition of this
approach in subsequent consultations) [11]. Hence, apply-
ing all steps of 5A may take 15min or more and can be dif-
ficult to implement during routine consultations. Since the
average time slot for GP consultations in Germany is often
not longer than 10min, most patients are unlikely to re-
ceive the full 5A protocol: research found the last two steps
(i.e., assist, arrange) to be least reported [30, 31], although
association with increased quitting is strongest for these
two steps of 5A [32]. Furthermore, a considerable number
of “unmotivated” smokers may still quit at a later stage
[28]. These smokers, according to 5A, would not be offered
treatment by their GP and are therefore less likely to use
evidence-based treatment to support their quit attempt.
In contrast to this so called “opt-in” approach of 5A
[33], the alternative “ABC” method (ask, brief advice, ces-
sation support), which has already been implemented and
replaced the 5A method in the New Zealand smoking ces-
sation guidelines [34], is usually applied as an “opt-out”
approach [33]. According to this approach, every smoking
patient should receive brief advice to quit together with an
offer of evidence-based smoking cessation treatment,
without assessing and discussing the patient’s current
motivation to quit. This approach is based on findings
showing that the mere offer of treatment – opportunistic-
ally in all smokers, regardless of their current level of
motivation – may trigger a quit attempt [35]. Moreover,
this method is less time consuming and much simpler to
apply than 5A. Hence, it can be assumed that ABC is
more convenient to apply at least during routine primary
care. However, so far, there is no evidence whether the 5A
or the ABC method should be preferred, or whether both
are equally effective in increasing rates of delivery of
medical advice to quit smoking.
In 2016, our research unit developed and pre-tested 3.5-
h-trainings for GPs according to 5A and ABC to improve
knowledge on, and practical skills in providing brief smok-
ing cessation advice according to the current national
guideline for treating tobacco addiction [10]. During the
process evaluation of a pilot study, qualitative data were
collected from participating GPs to further optimise the
training. Based on this pre-testing, the training concept
was finalised. As a strategy for the implementation of the
national clinical practice guideline for treating tobacco
addiction, both trainings will be evaluated regarding their
effectiveness to increase the rates of delivery of brief stop-
smoking advice by GPs during routine care.
The present study protocol describes a pragmatic 2-
arm cluster randomised controlled trial (cRCT) with a
pre-post-design for the primary outcome (evaluation of
the effectiveness of a training for GPs on the rate at
which they deliver brief stop-smoking advice during rou-
tine consultations with smoking patients), and a cluster
randomisation for the comparison of the effectiveness of
both training methods - 5A and ABC – against each
other (secondary outcome).
Preparatory work
Development of the training (intervention), training
manuals, and material
In 2016, the following preliminary work was carried out:
(a) detailed literature research and professional exchange
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with national and international colleagues; (b) develop-
ment of two 3-h-trainings on delivering brief advice to
quit smoking according to the 5A and to the ABC
method together with experienced GPs working at the
Institute of General Practice (ifam) at the Medical Fac-
ulty of the Heinrich-Heine-University (HHU) Düssel-
dorf; (c) preparation of clinical case vignettes of tobacco-
dependent patients for simulated role plays with profes-
sional actors (standardised patients, SPs) in close collab-
oration with the CoMeD team (Communication in
Medical education) of the HHU; and (d) development
and successive adaptation of training manuals. First
drafts of patient questionnaires were developed.
Pilot study
During the second half of 2016, a pilot study was carried
out to test recruitment procedures, content and sched-
ules of the training, practicability of training materials,
and methods of data collection.
In total, 14 GPs from 13 practices were recruited in
the German province North Rhine of the federal state
North Rhine-Westphalia (NRW) by postal dispatch of
information material and follow-up phone calls. GPs
were randomised to receive training in either ABC or
5A. Four trainings (two on each method respectively)
were carried out: 6 GPs participated in the 5A training,
and 8 in the ABC training.
All patients consulting their GP during a period of
4 weeks following the training were asked by the GP’s
practice nurse, prior to consultation, for their written
informed consent to participate in the trial. Consent-
ing patients were asked to fill out a baseline question-
naire on current daily and occasional tobacco use,
sociodemographic characteristics, and patients’ contact
data. Patients aged 18 years or above who stated to
smoke tobacco (cigarettes, hand-rolled or self-stuffed
cigarettes, pipe, or cigars) at least occasionally were
included in the pilot study.
Within the first week following the consultation with
the GP, smoking patients were contacted by telephone by
a researcher of the study centre, and were interviewed re-
garding planned outcomes of the main trial, e.g., on their
smoking behaviour, whether or not their GP delivered
advice to quit (according to 5A or ABC) during the last
consultation, and on their health-related quality of life
(EuroQol five dimensions questionnaire (EQ-5D) [36]).
One postal follow-up was conducted 4 weeks later, col-
lecting questionnaire data on further planned secondary
outcomes for the main trial (e.g., whether or not patients
had made an attempt to quit since the baseline consult-
ation with their GP, or on details about the trigger for
and the use of smoking cessation treatment during this
attempt (if so)).
This pilot study was approved by the ethics committee
of the medical faculty at the HHU Düsseldorf, Germany
(5354R).
Process evaluation, “lessons learned”, and adaptions to
the main study protocol
A process evaluation was carried out to gain deeper
insights into the feasibility and practicability of the train-
ing. To refine the training according to the needs of
GPs, problem-centred interviews with GPs of the pilot
study were conducted in the first half of 2017. GPs were
asked to report their experiences during the training, as
well as their perception about facilitating and inhibiting
factors for the access and on the transfer of the content
of the training into their daily routine.
Interviews were digitally recorded, transcribed verba-
tim, and analysed using content analysis [37, 38]. Data
analysis was conducted computer assisted (MAXQDA).
In a multi-professional team (psychology, sociology,
public health), core themes were identified to refine the
training manual for the cRCT.
Six interviews were conducted with GPs (4 women, 2
men, age range 41 to 61). Participants were included in
the qualitative study until saturation of data. The inter-
views lasted between 21 and 35 min.
GPs’ perspective
Balance of theoretical, reflective and practice elements,
standardization of role plays owing to professional
actors, peer coaching, and formal aspects (e.g., time
frame, setting, and date) of the training were positively
evaluated and met GPs’ needs for participating in med-
ical education. Motivation to assist patients with quitting
tobacco was high following the training, but effects on
the rate of successful quitters were expected to be small,
reflecting the GPs’ uncertainty about their role in smok-
ing cessation. Peer feedback during role plays was highly
appreciated, but SPs’ feedback was perceived as not
reflecting real patient-doctor-relationships. GPs reported
a need for informational material to pass on to patients.
Based on these results, the training manual was
further optimised:
➢ Educational objectives were added to the training’s
introductory lecture to strengthen GPs’ self-perception
as supporter and trigger of quit attempts rather than
being responsible for the quit attempt’s success.
➢ The duration of training was extended to 3.5 h in
order to enable more intensive role-plays with peer
feedback. Feedback from SPs was removed from the
manual.
➢ Additional information material was developed
including a leaflet referring to (local) smoking cessation
programs to pass on to patients.
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Study procedures
Based on these “lessons learned” regarding the data col-
lection within GP practices, the following modifications
were made to the study protocol and processes of data
collection of the main cRCT:
➢ Patient recruitment by practice nurses was
insufficient and could not be increased substantially by
providing financial incentives. Moreover, quality of
baseline data was low when patients had to complete
the questionnaire by themselves. Hence, in the main
cRCT, recruitment of patients and baseline data
collection including the primary and several secondary
outcomes, will be conducted by researchers of the
study centre through face-to-face interviews at the
practices. Thus, we aim to yield a maximum response
rate, improve the quality of the data, reduce the
number of missing values, and minimise recall bias.
➢ Following the trainings, GPs seem to have changed
their attitude towards the provision of brief stop
smoking advice. We therefore decided to collect data
on whether the training affects self-perception of GPs’
attitude towards, knowledge on, and practical skills in
the provision of brief advice to quit tobacco
consumption.
A final evaluation of the training manual and the
didactic methods was carried out together with experi-
enced GPs and peer trainers.
Methods/design main trial
Objectives
The primary objective is to assess the effectiveness of a
3.5-h-training for GPs in delivering brief advice to quit
tobacco consumption, irrespective of the training
method (5A or ABC), on patient-reported rates of deliv-
ery of such advice by their GPs during routine consulta-
tions in a German primary care setting.
Secondary objectives are
 to assess the effectiveness of the training,
irrespective of the training method, on patient-
reported rates of delivery of recommendations or
prescriptions of evidence-based smoking cessation
treatments to assist their quit attempt: (secondary
objective (S1) behavioural treatment (single or group
intervention), (S2) NRT, and (S3) varenicline or
bupropion;
 to assess the effectiveness of the training,
irrespective of the training method, on patient-
reported quit attempts (S4–6) and point-prevalence
abstinence rates (S7–9) at 4, 12, and 26 weeks after
GP consultation;
 to directly compare the effectiveness of the two
methods (5A vs. ABC) by means of the primary
outcome and the secondary outcomes S1–9 (S10).
Study design
The finalised training will be evaluated in a pragmatic 2-
arm cRCT with a pre-post-design (pre-training = care as
usual) for the primary outcome, and a cluster random-
isation for secondary outcome (comparison of the effect-
iveness of both training methods - 5A and ABC –
against each other) in approximately 48 GP practices
(cluster) in NRW (Germany) between June 2017 and
February 2020. The intervention will be a 3.5-h-training
for GPs in providing brief stop-smoking advice accord-
ing to the 5A or ABC method. Data on primary and on
several secondary outcomes will be collected prior to
and following the training by interviewing consecutive
patients of participating GPs. Further secondary data will
be collected by means of three follow-up questionnaires.
In total, there will be six study cycles with 8 participat-
ing GP practices per cycle. A study cycle is defined as a
period of 8 weeks with the training of GPs from four
practices in the 5A method and GPs from four practices
in the ABC method in the middle of this period. Data
collection will be carried out on approximately seven
varying GP office days during the 4-week pre-training
period and on 7 days during the 4-week post-training
period. Thus, we aim to minimise sampling bias which
could result from considerable fluctuations in patient
flow among different days or weeks of data collection
(e.g., on Mondays, during flu epidemic, or on holidays).
The distribution of study cycles over the total duration
of the study is shown in the Gantt chart of the study
(Fig. 1).
Setting and sample (participants)
The study will be coordinated at the ifam of the HHU
Düsseldorf. Figure 2 shows the flow chart of the study
according to the Consolidated Standards of Reporting
Trials (CONSORT).
Recruitment, eligibility, and randomisation
GP practices
GP practices will be mainly recruited from the publicly
accessible online medical register of the regional Associ-
ation of Statutory Health Insurance Physicians North
Rhine, and also from the shared GP practice network of
the institutes of general practice of the HHU Düsseldorf
and the University Witten/Herdecke. GPs will be in-
formed about the study and training dates, and invited
to participate by postal dispatch of study information
and follow-up phone calls. All GPs will be eligible for
participation, except for those specialised in treating
substance abuse or in psychotherapeutic care, or those
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Fig. 1 Gantt chart of the study illustrating the schedule of the total study, including the preparation period, pilot testing of the intervention, the
distribution of the six study cycles (intervention) over the total duration of the study, and all periods of data collection. P0 Process evaluation pilot
study, finalisation of training and manual, ethical approval, study registration. P1-P6 Preparations study cycles 1 to 6: practice recruitment, material,
application for CME certification, scheduling of trainings. B1-B6 Pre- (7 days) and post-baseline (7 days) data collection of primary and secondary
outcomes (S1-S3) in 8 GP practices per study cycle. T1-T6 Intervention: 3.5-h training of GPs in delivering brief stop-smoking advice according to
either 5A or ABC. F1-F6 Postal follow-up data collection of secondary outcomes (S4-S9) corresponding to study cycle 1–6
Fig. 2 Consolidated Standards of Reporting Trials (CONSORT) flow chart illustrating all steps in the study from enrolment to training allocation
and follow-ups. Inclusion and exclusion criteria are also specified as well as outcome measures
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who have already been trained in providing smoking ces-
sation support within the last 5 years, including GPs
who participated in the pilot study. Participating GPs
will have to give their consent to take part in a 3.5-h-
training in delivering brief stop-smoking advice and to
support a 4-week phase of data collection in their prac-
tice prior to and following the training.
Per study cycle, three to four potential training dates
will be offered. GPs will be asked to register at least for
two dates. Depending on the number of registrations per
training date, two different methods of randomisation
will be applied in each cycle:
A) If a sufficient number of GPs (> 8) will be available
at least at two of the proposed dates, computer-
generated block randomisation will be applied,
using random permuted blocks of sizes 2 or 4. The
randomisation sequence will be prepared in
advance by an independent statistician (WV) and
will be concealed from the researchers at the study
centre who are involved with the conduct of the
trial. The same method can be applied, if eight or
more GPs will register on the same date. Both
trainings (5A and ABC) will then be carried out on
the same day.
B) If fewer than eight GPs will be available at two of
the proposed dates, GPs will be randomised
“naturally” by virtue of the GPs temporal
availability. Two dates with most of the
registrations will be selected. GPs registered at the
first date will receive training according to the 5A
method. GPs registered at the second date will
receive training according to the ABC method. This
order will be alternated between cycles.
In order to prevent contamination, group practices
with more than one participating GP will be assigned to
the same study arm, depending on the allocation of the
GP from this group practice who is assigned first. If only
some of the GPs of a group practice participate in the
study, only patients of assigned GPs will be included in
the study. In case a GP has to cancel his or her partici-
pation in the training in the short-term, but pre-training
data collection was successfully completed (e.g., in study
cycle 3), this GP will be trained in the subsequent study
cycle (e.g., study cycle 4) to prevent drop-out of this GP.
Post-training data in his or her practice will then be col-
lected during the same study cycle in which the training
occurred (e.g., study cycle 4).
Patients
Patients 18 years or older visiting participating GPs dur-
ing a study cycle will be asked for to provide informed
consent to participate in the study. Patients suffering
from moderate or severe cognitive impairment, or those
of too low literacy, will be excluded. Moreover, patients
who will not talk to their GP in person will be excluded
(e.g., patients who just come to pick up a prescription or
to escort a relative).
The study team involved in the data collection con-
sists of four part-time researchers (Bachelor/Masters’
degree in psychology, public health, and health eco-
nomics). Each researcher can manage data collection
in two of the eight GP practices in each study cycle.
Prior to data collection, the researchers will inform
nurses in participating GP practices about the study
schedule, and ask for assistance regarding patients
who do not meet the inclusion criteria. Posters and
leaflets promoting the study will be provided to the
practices.
During a data collection day in the practice, patients
will be informed about, and invited to participate in the
study by the researcher in the waiting room, prior to
their consultation with the GP. Consenting patients will
be asked to participate in a brief interview immediately
following this consultation. At this time, patients will
not be fully informed about the real purpose of the
study, because addressing the topic of smoking at this
time could trigger patients to initiate a discussion about
their smoking during the consultation. Hence, prior to
the consultation, patients will be asked to participate in
a study on “physician-patient communication on health
behaviour”. This strategy has been approved by the
ethics committee.
Brief interviews (~ 10–15 min) to collect baseline
data (see Additional file 1, translated versions are also
provided) will be conducted consecutively with every
single patient. All patients will be asked on sociode-
mographic characteristics (e.g., age, sex, level of edu-
cation), health-related quality of life, and on smoking
status. Never and ex-smokers will receive full infor-
mation on the purpose of the study and the interview
will be interrupted at this moment. Patients who only
use electronic cigarettes or heat-not-burn products
but who do not smoke tobacco cigarettes will also be
excluded at this moment. Furthermore, those patients
will not be included in any follow-up data collection.
Current daily and non-daily tobacco smokers (ciga-
rettes, cigarillos hand-rolled cigarettes, pipe, cigar, or
hookah) will be further interviewed on their smoking
behaviour, motivation to stop smoking [28], strength of
urges to smoke [39], as well as on primary and second-
ary outcomes. At the end of this interview, patients will
be informed about the purpose of the misinformation
regarding the interview content according to the re-
quirements of the ethics committee.
By assessing the above-mentioned primary and
secondary outcomes immediately after GP consultation
Kastaun et al. BMC Family Practice          (2019) 20:107 Page 7 of 18
through a face-to-face interview, we aim to maximise
response rates and minimise recall bias.
Blinding
Due to the pragmatic nature of the study design it will
not be possible to fully blind GPs to their training alloca-
tion (5A or ABC method). However, to minimise pos-
sible systematic bias, where GPs tend to make more
effort in delivering brief advices to quit depending on
the training method they were allocated to, we aim to
reduce the information on the group allocation until the
end of the 4-week pre-training data collection period. In
particular, during the recruitment process and during
the pre-training period, GPs will only be informed that
the implementation of the brief advice in GP practices is
being examined and that the effect of two different brief
advice methods is compared. The GPs, however,
received no information about the content and the
difference of both methods.
Initially, we planned to blind the researchers conduct-
ing the baseline data collection to the GPs’ group alloca-
tion. However, with eight GPs per study cycle and four
part-time researchers collecting data in their practices, it
will not be feasible to conceal group allocation to the
study team. In order to prevent that GPs behave differ-
ently depending on the person collecting data in their
practice, these researchers will not be actively involved
in the training of the GPs.
Intervention
Depending on their group allocation, GPs will receive
training on the delivery of brief stop-smoking advice ei-
ther according to the 5A or to the ABC method. Both
types of training will be conducted in accordance with
the national and international guidelines on smoking
cessation [10, 11]. In both groups, the training will be
organised at a central location (i.e., the HHU in Düssel-
dorf ), and will have a duration of approximately 3.5 h
starting at a time which is feasible and familiar to GPs
(late afternoon/early evening on Wednesdays and
Fridays, or on Saturdays). In order to avoid seasons of
high workload, and to avoid a low reach of patients
during holiday periods, study cycles will primarily be
carried out during the months February/March 2018/
2019, September/October 2017/2018, and May/June
2018/2019 (Fig. 1).
Both types of training will include an introductory lec-
ture of approximately 60 min about tobacco addiction,
evidence-based smoking cessation treatments, and about
the specific method of stop-smoking advice (either 5A
or ABC). Reflexive units and discussions on GPs’ experi-
ence with the provision of stop-smoking advice, and on
associated barriers and facilitators, will also be a part of
the introductory lecture.
This lecture will be followed by an intensive role play
of about 90–120min with professional actors trained in
patients’ specific behaviour. In these role plays, GPs get
to practise the respective training method and receive
moderated feedback (see below for further details re-
garding the content). Training sessions will always be
led by a pair of trainers: a senior researcher of the study
centre and an experienced GP (peer-trainer) who can
specifically address the questions and needs of daily GP
routine. For both types of training, the number of partic-
ipants will be restricted to a minimum of three and a
maximum of ten (in case of participating group prac-
tices). A detailed manual has been developed which the
trainers should refer to. Thus, we aim to standardise the
contents, schedule, and quality of each training session
as much as possible. In order to avoid that the quality of
training sessions differs between 5A and ABC, and
might thus impact the study outcome, we will rotate the
pairs of trainers from study cycle to study cycle. Face
validity of the training was assessed during the pilot
study and will be assessed again during a test run prior
to the start of the main trial, where trainers, actors, and
two practicing GPs will rehearse and review the clinical
vignettes for the role plays which have been planned in
close collaboration with the CoMeD at the HHU
Düsseldorf.
The CoMeD team is engaged in the training of profes-
sional actors to become an SP and learn how to give
constructive feedback for simulated role plays in medical
communication education. Different types of, for ex-
ample tobacco addicted, patients can be portrayed by
one SP. These SP trainings are a major element in order
to guarantee high quality education of patient-physician-
communication [40].
Both trainings will teach GPs how to ask patients
about smoking (A1) and how to advise them to stop
(A2). The 5A training will specifically teach GPs how to:
assess the patients’ willingness to quit (A3) and how to
apply the 5R approach in patients who are not willing to
quit; assist the quit attempt (A4); and arrange follow-up
(A5). The ABC training will specifically teach GPs how
to make the offer of treatment (A4) opportunistically
(e.g., a prescription for NRT, or a referral to individual
or group behavioural support; irrespective of the
patients’ motivation to stop at the time of the consult-
ation). In addition to the training, GPs from both inter-
vention groups will receive paper-based leaflets
summarising the key aspects of 5A or ABC, a one-page
handout with short information on evidence-based
smoking cessation treatments which can be offered to
patients, as well as a one-page copy template with
several local outpatient programs to which smoking pa-
tients can be referred to. The completion of the training,
irrespectively of the method, will be incentivised with
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Continuing Medical Education (CME) credits. Material
for GPs of both groups will be of exactly the same
quality and adhere with common standards for CME.
Considering the above, it can be assumed that the 5A
training would require more time than the ABC training.
However, during the pilot study, we noticed that teach-
ing the ABC method demands extra time for group dis-
cussions on offering smoking cessation treatment
irrespective of patients’ motivation to stop, as GPs seem
less familiar with this opportunistic approach. Hence,
duration was kept the same for both trainings.
Theoretical foundation of the intervention: COM-B model
The theoretical foundation of the intervention is based
on the “COM-B” model developed by Michie and col-
leagues [27]. According to this model, the interaction
between the three components capability (C), opportun-
ity (O), and motivation (M) causes the performance of
behaviour (B). Each component influences behaviour
and, moreover, capability and opportunity influence
motivation and therefore affect behaviour. COM-B is a
dynamic model whereby performance of a specific be-
haviour can in turn influence capability, opportunity,
and motivation. Interventions need to change one or
more of the components in such a way as to put the
system into a new configuration. Interventions need to
change one or more of the components in such a way as
to achieve a desired change in behaviour.
According to studies which explored barriers to the
promotion of smoking cessation in German primary
care, GPs often lack the feeling of competence in giving
cessation advice (capability: knowledge, practical skills)
[17–19], inadequate reimbursement of costs (opportun-
ity) involved in the promotion of smoking cessation and,
additionally, rate these conversations to be too time con-
suming (capability, motivation) [17, 41]. In our trainings,
we aim to address at least these two components
(capability and motivation) of the COM-B Model and
expect that this might affect the GPs’ behaviour of offer-
ing brief stop-smoking advice to their smoking patients
during routine consultation. Moreover, it can be
hypothesised that giving brief stop-smoking advice
according to ABC might influence the component
opportunity because this method is less difficult and less
time consuming to apply, and can be integrated more
easily into the daily practice routine.
For a better description of the main active elements of
the developed trainings, we aim to use the Behaviour
Change Techniques (BCT) Taxonomy from Michie and
colleagues [42]. A training session can be categorised in
three superordinate elements: (1) introductory lecture,
(2) practice element with role plays, and (3) reflexive ele-
ments. Reflexive elements, however, also occur in group
discussions during the role plays or following the intro-
ductory lecture. BCTs that will be applied during each
training session are listed in Table 1.
Outcomes
Primary outcome
The primary outcome is defined as the number of pa-
tients who report the receipt of brief stop-smoking ad-
vice during the last consultation with their GP,
irrespective of the training method, out of the total
number of patients who stated to be current tobacco
smokers at the time of the consultation with their GP.
These data will be collected prior to and following the
training through personal interviews in all consecutive
patients immediately following GP consultation.
Secondary outcomes
Secondary outcomes S1–3 will be collected together
with the primary outcome through personal interviews
immediately after GP consultation and refer to the
patients’ last consultation with their GP. Data on
secondary outcomes S4–9 will be collected by means of
three follow-up questionnaires by postal dispatch. The
denominator of all secondary outcomes is the number of
patients who stated to be current tobacco smokers at
the time of the consultation with their GP.
 S1: Number of patients who report the receipt of a
recommendation for individual or group behavioural
support for smoking cessation;
 S2: Number of patients who report the receipt of a
recommendation or prescription of NRT for
smoking cessation;
 S3: Number of patients who report the receipt of a
recommendation or prescription for varenicline or
bupropion for smoking cessation;
 S4–6: patient-reported rates of quit attempts after 4, 12,
and 26weeks following the consultation with the GP;
 S7–9: patient-reported point prevalence abstinence
rates at 4, 12, and 26 weeks following the
consultation with the GP;
 S10: Interaction effect between time (from pre-to
post-training) and group variable (5A vs. ABC) for
the primary and secondary outcomes S1-S9.
Furthermore, this study aims to assess additional data in
GPs on to what extent one 3.5-h-training session accord-
ing to either the 5A or the ABC method affects, at least in
the very short-term (immediately following the training),
self-perception of GPs’ attitude towards (motivation),
knowledge on, and practical skills (capability) in the
provision of brief advice to quit tobacco consumption.
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Table 1 Exemplary contents of the ABC and 5A training with corresponding codes and labels according to the Behavior Change
Technique (BCT) Taxonomya
Superordinate elements of
training
BCT groupa BCT code and labela Examples from the training or training manual
1 Introductory lecture 1 Goals and planning 1.2 Problem solving Prompt GPs to identify barriers preventing
them from starting a conversation on
smoking cessation during routine
consultations and discuss potential solutions.
For example how to advise patients with
multiple unsuccessful quit attempts in their
history, how to start a conversation on
smoking cessation with patients having no
smoking-related problems.
4 Shaping knowledge 4.1 Instruction how to
perform the behaviour
Inform GPs verbally on how to provide brief
advice to stop-smoking according to 5A/ABC
with examples of different types of patients.
5 Natural consequences 5.1 Information about
health consequences
Inform GPs verbally on health risks of smoking
and benefits of smoking cessation, and on the
role of GPs in reducing smoking prevalence
on a population level.
5.6 Information about
emotional consequences
Pointing out that the provision of brief-stop
smoking advice aims at triggering a quit
attempt rather than long-term abstinence in
every smoker receiving such an advice.
Lowering high or delusive expectation should
lead to a reduction of frustration, and thus
increase self-efficacy.
Only ABC training: Provide information on
how application of the ABC method to deliver
brief-stop smoking advice (without discussing
patients’ motivation to quit) can reduce stress
and frustration in daily GP routine, and thus
increase satisfaction.
6 Comparison of behaviour 6.1 Demonstration of the
behaviour
Demonstrate to GPs how to raise the issue of
smoking cessation with patients indirectly via
pictures of exemplary patient-physician
conversations.
6.2 Social comparison Providing information on the proportion of
smokers in Germany who were offered GP
advice on quitting by their GP, thus they can
compare with their own performance.
6.3 Information about
others’ approval
Telling GPs that smoking patients will
appreciate a conversation on smoking
cessation including the provision of support/
assistance rather than a conversation with
criticism or reproaches causing feelings of
guilt in patients.
7 Associations 7.1 Prompts and cues Provision of handouts for GP practice rooms
to remind them of delivering brief stop-
smoking advice to all smoking patients:
including: the 5A/ABC method, behaviour
change techniques for patients (e.g. setting a
quit day), the Fagerström Test for Cigarette
Dependenceb, information on evidence-based
smoking-cessation therapy, contact
information: smokers’ telephone helpline,
regional group-based smoking cessation
programs).
8 Repetition and
substitution
8.2 Behaviour substitution ABC: Suggest that GPs should not ask for
patients’ motivation to stop smoking and
provide their assistance instead to every
smoking patient regardless of motivational
status.
5A/ABC: Suggest that GPs provide stop
smoking support as a brief or very brief
conversation on smoking cessation rather
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Table 1 Exemplary contents of the ABC and 5A training with corresponding codes and labels according to the Behavior Change
Technique (BCT) Taxonomya (Continued)
Superordinate elements of
training
BCT groupa BCT code and labela Examples from the training or training manual
than as a time consuming and exhausting
discussion.
9 Comparison of outcomes 9.1 Credible source Presentation of evidence-based data (e.g., data
from Cochrane reviews) on the importance
and effectiveness of brief GP advice to stop-
smoking.
11 Regulation 11.2 Reduce negative
emotions
Advise GPs how to reduce frustration during
stop smoking conversations (e.g., through
realistic goal setting: aiming to trigger a quit
attempt rather than long-term abstinence in
smoking patients).
13 Identity 13.2 Framing/reframing Cognitive structuring: Suggest that medical
advice on quit smoking must not necessarily
be time consuming and exhausting (which
are frequently reported barriers preventing
GPs from raising a stop-smoking
conversation).
2 Practice elements (Role
plays with peer feedback)
1 Goals and planning 1.1 Goal setting (behaviour) GPs are encouraged to apply all the steps of
ABC/5A during the role play and therefore
change their familiar patterns of behaviour
during conversations on smoking cessation.
1.2 Problem solving Discussions during role plays: prompt GPs to
identify barriers preventing them from
applying a specific step of 5A or ABC (“Which
steps of 5A or ABC could you (not) apply
during the role play, and why or why not?”
“What could have helped/could be changed
during in this situation?”).
1.5 Review behaviour
goal(s)
Examine how well a GP’s performance during
role play corresponds to agreed goals (e.g.,
applying all steps of the 5A/ABC method, or
providing brief advice on quitting to the
patient without reproaches or criticism); and
consider a modification of a behavioural goal,
e.g. through realistic goal setting: aiming to
trigger a quit attempt rather than being
responsible for the quit attempt’s success.
1.6 Discrepancy between
current behaviour and goal
Trigger a quit attempt rather than long-term
abstinence in smoking patients;
Trainer and peers point out and discuss which
steps of 5A or ABC had not been applied
during role play.
2 Feedback and monitoring 2.2 Feedback on behaviour
2.7 Feedback on outcomes
of behaviour
Peers and trainers provide moderated
feedback on GP’s behaviour/ performance and
on observed outcomes (reactions) of patient
(actor) during role plays.
3 Social support 3.2 practical support
3.3 emotional support
Peers and trainers provide practical and
emotional support during role plays: e.g.,
advise on how to cope with a specific patient
reaction.
4 Shaping knowledge 4.1 Instruction how to
perform the behaviour
Repeated instructions (verbal) are provided by
the trainers prior to the role plays: how to
provide brief advice to stop-smoking
according to 5A/ABC.
5 Natural consequences 5.4 Monitoring of
emotional consequences
GPs are encouraged to reflect and reveal their
feelings during active role play.
6 Comparison of behaviour 6.1 Demonstration of the
behaviour
Provision of role plays with moderated
feedback to practice the delivery of brief stop-
smoking advice according to 5A/ABC.
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Data collection
General practitioners
A brief questionnaire will be administered to GPs
prior to the training to collect information on the
characteristics of the participating GPs (including age,
gender, smoking status, professional experience, and
specialisation) and the practice characteristic, such as
location (rural vs. urban), average number of patients
per calendar quarter.
Within the 4 weeks prior to and immediately following
the training, GPs will be asked to fill out a brief
questionnaire to collect data on their attitude towards
(motivation), knowledge on, and practical skills (capabil-
ity) to provide brief stop-smoking advice during routine
Table 1 Exemplary contents of the ABC and 5A training with corresponding codes and labels according to the Behavior Change
Technique (BCT) Taxonomya (Continued)
Superordinate elements of
training
BCT groupa BCT code and labela Examples from the training or training manual
6.2 Social comparison GPs are encouraged to observe the
performance of colleagues during role play
allowing comparisons with their own
performance during role play but also during
past routine practice consultation.
6.3 Information about
others’ approval
Peers and trainers provide feedback on the
performance of the GP who participates in
the role play.
8 Repetition and
substitution
8.1 Behavioural practice/
rehearsal
Provision of role plays with moderated
feedback to practice the delivery of brief stop-
smoking advice according to 5A/ABC.
8.2 Behaviour substitution Trainer and peers suggest alternative
reactions/sentences during role plays
corresponding to the 5A/ABC method (e.g.,
ABC: providing assistance with attempt to quit
rather than discussing patients’ motivation to
quit smoking).
9 Comparison of outcomes 9.1 Credible source GP peer trainer reports on own positive
experiences but also on challenges with the
provision of brief stop-smoking advice
according to either the 5A or ABC method.
13 Identity 13.2 Framing/reframing Providing measurements on the exact
duration (minutes) of role-play in order to
demonstrate that the provision of brief advice
on quit smoking must not necessarily be time
consuming, which is a frequently reported
barrier preventing GPs from raising a stop-
smoking conversation.
3 Reflexive elements
(Group discussions at the
beginning and end of the
training)
1 Goals and planning 1.1 Goal setting (behaviour) Prompt GPs to set a self-defined goal for the
next working day regarding the provision of
brief stop-smoking advice with the so-called
“Monday-Question”: “What would you
change/ do differently next Monday in
practice?”.
9 Comparison of outcomes 9.2 Pros and cons Encouraging GPs to reflect the advantages
and disadvantages of providing brief stop-
smoking advice (more often) to their smoking
patients.
13 Identity 13.3 Incompatible beliefs Drawing attention to discrepancies between
GPs’ current or past performance regarding
the provision of advice to quit smoking and
his or her self-image as a health consultant.
15 Self-belief 15.3 Focus on past success Encourage GPs to reflect strategies which
helped them in the past to have a successful
conversation on smoking cessation with a
patient.
aTaken from Michie, S., Richardson, M., Johnston, M., Abraham, C., Francis, J., Hardeman, W., Eccles, M. P., Cane, J. & Wood, C. E. (2013). The Behavior Change
Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions.
Annals of Behavioral Medicine, 46(1), pp. 81–95. doi: 10.1007/s12160-013-9486-6. Available from: https://link.springer.com/article/10.1007/s12160-013-9486-6.
(Accessed 30.07.2018)
bFagerström, K. Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence Nicotine Tob Res (2012) 14 (1): 75–78
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consultations. In this questionnaire, GPs will be asked to
indicate whether they are aware of the steps of the desig-
nated method, whether they provide brief stop-smoking
advice regularly or not, whether they think that provid-
ing brief advice to their smoking patients is important,
effective, and feasible in GP practices, and whether they
are confident in providing such advice, respectively
according to either 5A or ABC. Answering options will
be: (1) “strongly support”, (2) “support”, (3) “tend to
support”, (4) “oppose”, (5) “strongly oppose”.
Patients
Baseline measurements
Following the consultation with their GP, a researcher of
the study team will immediately conduct the brief
baseline interview (~ 10–15 min) with the study (see
Additional files 1 and 2). At the beginning of the inter-
view, all patients will be asked about their age, sex, level
of education, employment status, and health-related
quality of life (EQ-5D [36]).
Patients will then be asked whether they smoke to-
bacco (cigarettes, hand-rolled cigarettes, pipe, cigar, or
hookah). Answer categories will be: (1) “Yes, I currently
smoke on a daily” or (2) “on a non-daily basis”, (3) “No,
but I used to smoke in the past”, (4) “No, I have never
smoked daily or occasionally”.
Current smokers of tobacco products will be asked
further details on their smoking behaviour: how long
it has been since they had smoked their last cigarette,
the average number of cigarettes (or, e.g., pipes, ci-
gars) they smoke per day, week or month (for occa-
sional smokers), on their motivation to stop smoking
(German version of the Motivation to Stop Smoking
Scale, MTSS [28]), and their strength of urges to
smoke (German version of the Strength of Urges to
Smoke Scale, SUTS) [39]. These variables represent
important co-variates or confounders for the planned
statistical analyses.
Subsequently, data on the primary outcome will be
collected. Smoking patients will be asked whether their
GP started a conversation on the patient’s smoking be-
haviour during the preceding consultation at the same
day. If the answer is “yes”, these patients will be asked
whether or not their GP provided brief advice to quit
smoking according to either 5A or ABC during the pre-
ceding consultation. This is operationalised by whether
the GP asked for the smoking status (A1: both 5A and
ABC), urged the smoker to quit (A2: both 5A and ABC),
asked for the patients’ motivation to quit smoking (A3:
only 5A), provided evidence-based stop-smoking therapy
(A4: both 5A and ABC) by recommending or prescrib-
ing either: individual or group behavioural support (S1),
NRT (S2), varenicline or bupropion (S3); and arranged a
follow-up appointment (A5: only 5A). Furthermore,
recommendations of a combination of therapies will be
asked (e.g., “my GP recommended or prescribed me
individual or group behavioural support AND NRT).
Patients reporting the receipt of any brief smoking ces-
sation counselling will be asked about their satisfaction
with that conversation; operationalised by ratings on a
6-point Likert scale ranging from 1 = “very satisfied” to
6 = “very dissatisfied”).
Follow-up measurements
Four (time window = + 1 week), 12, and 26 weeks (time
windows = + 2 weeks, respectively) after consultation with
their GP, patients who reported to be a tobacco smoker at
baseline will receive a follow-up questionnaire (see
Additional files 3 and 4) by postal dispatch. This question-
naire collects data on secondary outcome (S4-S9): whether
or not patients have made an attempt to quit from base-
line (GP consultation) to follow-up, and on their current
smoking status (S 7-9= point prevalence abstinence rates).
In relation to this, questions will be asked about what
triggered that attempt (e.g., advice of GP, smoking-related
disease, cigarette package health warnings), whether it was
supported by evidence-based (e.g., NRT) or non-evidence-
based smoking cessation treatments (e.g., acupuncture,
hypnosis), and how long this attempt to stop did last (if
so). In order to avoid overlaps with further consultations
or multiple quit attempts which might have taken place
since the initial consultation, the questions will be clearly
formulated with reference to specific dates or periods. To
assess changes within the health-related quality of life
from consultation to follow-up, a paper-based version of
the EQ-5D will be sent along with each follow-up
questionnaire.
Patients will receive a small unconditional and non-fi-
nancial incentive together with each follow-up, which is
an evidence-based strategy to increase the response rates
[43–45].
Power and sample size
Based on recent data from a study of the German popu-
lation [13], we assume that about 18% of smokers are
currently receiving brief advice on smoking cessation
during a consultation with their GP. Training in either
the 5A or ABC method is assumed to have a clinically
relevant effect if it increases these rates by at least 10%
(corresponding to an odds ratio of 1.77) between pre-
and post-training.
Calculation of the required sample size is based on the
primary analysis and is intended to ensure that a signifi-
cant time effect between pre- and post-training can be
detected with a probability of 80%, taking into account
the clustering of patients in GP practices. The following
assumptions were made: (a) 48 GP practices will be
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recruited (six study cycles with 4 GPs receiving the 5A
training and 4 GPs receiving the ABC training each
cycle); (b) the delivery rate of brief cessation advice prior
to the training is 18%; (c) these rates vary among prac-
tices with assumed ranges from 9 to 32% in 95% of the
practices (corresponding to a standard deviation (SD) of
0.40 on the logit scale); (d) the chance of receiving stop-
smoking advice increases on average from 18 to 23%
(5A method) or 33% (ABC method) after a training; and
(e) varies among practices after the training (between 12
and 40% (5A method) or between 18 and 52% (ABC
method) in 95% of the practices (equivalent to a SD of
0.05 for the time effect on the logit scale).
A simulation study based on these assumptions
showed that 16 patients (respectively 8 prior to and
8 following the training) per practice are needed to
evaluate the primary outcome with a statistical
power of at least 80%. A total of 42 patients per
practice (21 before and 21 after training) are needed
to yield the same power when analysing the inter-
action between the time and group variable (second-
ary outcomes S10), resulting in a total study sample
size of 2016 patients (respectively 1008 prior to and
1008 following the training). The R-code of this
simulation can be provided on request.
Patient participation rates are estimated from data
of an earlier study on smoking cessation interventions
in GP practices in Germany [46] and on current
prevalence rates of smoking in Germany at the mo-
ment of developing the study [3]: The number of pa-
tients visiting their GP per day is ~ 19, about 28%
(n = ~ 5) of them are smokers; about 60% of these
smokers (n = ~ 3) meet the inclusion criteria and are
willing to participate in the short interview following
the consultation with their GP (primary outcome and
secondary outcomes S1-S3). Per study cycle, data col-
lection will be carried out on 7 working days during
the 4-week pre-training period and on full 7 working
days during the 4-week post-training period, resulting
in data from 21 smoking patients prior and 21
smoking patients following the training in each prac-
tice (~ 42 smoking patients per practice).
Planned statistical analyses
Descriptive statistics
Demographic data of patients (e.g., age, gender, edu-
cation, employment status, smoking characteristics)
and data of GPs (e.g., age, gender, smoking status,
practice characteristic) will be described for the total
group and for the study arms separately. Continuous
variables will be presented with means, and SD. Cat-
egorical variables will be denoted in numbers and
percentages. Differences in sociodemographic or
practice characteristics among patients and GPs of
the two study arms will be analysed using Student t-
tests, or non-parametric Mann-Whitney U tests. For
categorical variables, Pearson χ2 or Fisher’s exact
test will be used.
Analyses of primary and secondary outcome measures
The primary endpoint is dichotomous: patient re-
ported receipt of brief stop-smoking advice delivered
by the GP during the preceding consultation (yes or
no). Hence, analyses of the primary outcome will be
conducted using logistic regression models. Data are
structured hierarchically (in clusters = practices), with
the patients located within the practices. Since differ-
ences in rates of delivery of smoking cessation advice
are expected among the practices, mixed effect
models will be used. For the primary analysis, the
model contains a fixed effect for time (dichotomous:
pre- versus post training) and random effects for the
practices and the time effect. This model will be ad-
justed for potential confounders measured at baseline:
age, sex, SES, motivation to stop smoking, and
strength of urges to smoke of the patients.
The same model will be applied to the secondary out-
comes S1-S3 (recommendation of behavioural treat-
ment, NRT, or medication), S4-S6 (patient-reported quit
attempts at 4, 12, and 26 weeks following the consult-
ation with the GP), and S7-S9 (patient-reported abstin-
ence at 4, 12, and 26 weeks following the consultation
with the GP).
In order to analyse differences between the 5A and
ABC training (secondary outcome S10), the group vari-
able (dichotomous: 5A or ABC training) and its inter-
action with time will be added to the models as fixed
effects. In both models, the time effect and the inter-
action will be analysed by means of Wald tests (level of
significance .05).
All participating patients will be included in an
intention-to-treat analysis. The risk for missing data
on the primary outcome and secondary outcomes
S1-S3 will be relatively small, as these data will be
collected though personal interviews. However, miss-
ing data will be imputed and recoded as patient-re-
ported “no advice-to quit delivered by GP” (primary
outcome) and “no treatment recommended or deliv-
ered by GP” (S1-S3). To examine the sensitivity of
the results, a complete case analysis will be per-
formed additionally, which means that all cases with
missing data on the primary outcome will be
excluded from the analysis. Missing data on second-
ary outcomes S4-S6 will be imputed and recoded as
“no quit attempt”. Missing data on secondary out-
comes S7-S9 will be imputed and recoded as
“smoker” at follow-up.
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Trial status and timescale
As of January 2019 (revision of the manuscript), the re-
cruitment of GPs and patients had started but had not
yet been completed. Data collection including all follow-
ups is expected to be completed in February 2020
(Fig. 1).
Discussion
Given the high number of patients regularly consulting
their GP in Germany, primary health care represents the
optimum setting for the identification of smokers and
the provision of evidence-based smoking cessation treat-
ment to take place. This is addressed in the national
guideline for treating tobacco addiction [10], but imple-
mentation of this guidance in clinical practice is inad-
equate. Hence, there is an urgent need for strategies that
can improve the implementation of this guideline in the
primary health care setting.
Central factors which have been identified as barriers to
the promotion of advice on smoking cessation comprise
the lack of training and lack of time to provide appropriate
advice during routine consultations [17–19]. Interventions
aiming to improve the guideline implementation should
therefore be as little time consuming as possible to intern-
alise and to apply, and have the potential for a broad im-
plementation in clinical practice. However, most primary
care studies so far evaluated trainings with an intensity of
several hours up to days, sometimes in combination with
refresher trainings [21, 23]. Only a few recent studies
suggest that even short training sessions seems to have an
effect on the performance of GPs in delivering brief be-
havioural support [25, 26]. We therefore developed two
3.5-h-trainings as a strategy for the implementation of the
national clinical practice guideline for treating tobacco.
Both trainings aim to improve at least two of the three
determinants (capability and motivation of GPs to deliver
brief stop-smoking advice) causing the performance of
behaviour according to the COM-B theory [27].
Due to a lack of evidence, the national guideline [10]
cannot recommend whether the 5A or the ABC method
to deliver brief medical advice to quit smoking should
be preferred, or whether both are equally effective. Since
ABC, as an “opt-out” approach, seems to be less time
consuming and less frustrating to GPs, we assume it to
be more convenient to apply at least during routine pri-
mary care. Evidence regarding this hypothesis comes
from studies showing that the majority of physicians
delivers only the first three 5A steps (“ask, advice,
assess”) [30, 32], although “assist” and “arrange” are
those steps associated with increased quitting [32].
The present study might help to develop a strategy to
improve the implementation of brief stop-smoking
advice in German primary care. The findings might also
help fill a knowledge gap on the effectiveness of two
different methodological approaches, the “opt-in” (5A)
versus the “opt-out” (ABC) approach to provide brief
advice to quit smoking. Moreover, data of this study will
give further insight on processing data, e.g., barriers and
facilitators for the implementation of the clinical
guideline on the treatment of tobacco addiction into
clinical practice.
Strengths and limitations
This study is the first to evaluate the effectiveness of a
relatively brief training intervention according to the 5A
method in contrast to the ABC method to deliver brief
stop-smoking advice during routine consultation in GP
practices in Germany. Effectiveness will be measured by
means of patient reports. Role plays with professional
actors trained in portraying different types of smoking
patients as standardised as possible are an essential
element of both developed trainings. It has been shown
that such role plays with trained SPs are one principal
element in order to guarantee high quality education of
patient-physician-communication [40].
The randomised controlled study design will reduce
the risk of selection as well as interpretation bias. In this
study, data on the primary and several relevant second-
ary outcomes will be collected in patients immediately
following the consultation with the GP minimising the
risk of missing data as well as the risk of recall bias. The
pragmatic approach with relatively unselected partici-
pants and under real-practice conditions strengthens the
external validity of the results and may provide meth-
odological and processing data for subsequent imple-
mentation studies. Moreover, if the training is proven to
be effective, its briefness might further facilitate a broad
implementation in primary health care.
However, several challenges associated with the prag-
matic nature of this study need to be addressed. First of
all, as with most interventional studies in primary care, a
bias on the selection of GPs is expected, with higher
participation rates of GPs with interest in the topic of
smoking cessation support and with the possibility or
motivation to participate in further training activities.
This effect may be assumed to be equally distributed
over the study arms. If our hypothesis can be confirmed,
the offer of individual GP trainings held at the practice
sites might be one solution to allow the implementation
of the intervention also in practices with less motivated
GPs or with those without the opportunity to take part
in group trainings due to massive workload or other
structural or organizational barriers.
The presence of a researcher of the study centre for
the purpose of data collection could trigger and increase
the performance of GPs, and thus lead to an overesti-
mation of the patient-reported rates of brief stop-smok-
ing advice delivered by their GP. However, this is not
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expected to distort the main findings of the study since
the primary outcome will be evaluated by means of the
relative difference between pre- and post-training mea-
surements. In contrast, face-to-face interviews with pa-
tients assessing smoking-related outcomes, even if such
conversations cannot be formally seen as smoking cessa-
tion counselling, might act as a potential trigger for subse-
quent quit attempts (secondary outcome) which cannot
be completely prevented. Nevertheless, researchers con-
ducting these interviews will be obliged to refrain from
providing any counselling on smoking cessation, and since
secondary outcomes will also be evaluated by means of
the relative difference between pre- and post-training
measurements, we could at most expect to find a ceiling
effect regarding this outcome.
Due to the pragmatic nature of this study, GPs and re-
searchers cannot be blinded to the allocation of both study
arms. In order to reduce contamination, we recommend a
standardised routine for each researcher while collecting
patient-data, e.g., aiming to avoid comments or discussions
on the intervention (5A vs. ABC training) while talking to
GPs or patients. Moreover, self-reflection and peer supervi-
sion during team meetings will be used to minimize and
document potential biases on a regular basis.
In this study, primary and important secondary out-
comes are measured immediately following the training.
Any effect on these outcomes is therefore expected to
decrease after a longer period of time. If this study
shows that our training is effective in increasing the
rates of delivery of brief GP advice on quitting, long-
term effects need to be evaluated with further research.
Smoking status in this study, measured as a secondary
outcome at follow-up, will be assessed by self-report and
not be biochemically verified. However, over-reporting
of smoking abstinence may be assumed to be equally
distributed over the study arms, may not differ between
pre- and post-training measurement, and in studies with
no or only limited face-to-face contact, the use of bio-
chemical verification is not necessarily required [47].
Finally, the study will be conducted in the federal state
of NRW. Results can thus not be entirely generalised to
GP practices across all provinces of Germany. However,
NRW is the fourth largest of the German federal states
and represents an agglomeration of urban and rural
areas with a broad socioeconomic variability. Sound
representativeness of data is therefore assumed.
If the training increases the rates of delivery of stop-
smoking advice, ideally together with a recommendation of
an evidence-based smoking cessation treatment, it would
offer a low-threshold strategy for the implementation of the
national clinical guideline on treating tobacco addition in
primary care as well as of the implementation recommen-
dations of the WHO-FCTC Article 14. Should one of the
training methods, 5A or ABC, prove superior, a more
specific guideline recommendation can be proposed for pa-
tient care. However, even a broad implementation of an ef-
fective intervention in primary care cannot entirely cover
the lack of reimbursement of costs that come along with
smoking cessation treatment and the absence of established
specialist cessation services which have been shown to be
highly effective [48]. This remains a debate for politics.
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